Prothena Corporation plc Company Profile
NASDAQ: PRTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.48+0.46 (+5.74%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 8.48 0.00%
Prothena at a glance
Prothena Corporation plc (NASDAQ: PRTA) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. At a market capitalization of $411.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001559053, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Prothena Corporation plc
- Ticker
- NASDAQ: PRTA
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- Market cap
- $411.72M
- SEC CIK
- 0001559053
Companies similar to Prothena
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AVIRAtea Pharmaceuticals Inc. | 5.01 | -1.18% | $401.83M | vs PRTA |
| RZLTRezolute Inc. | 4.38 | +1.39% | $423.64M | vs PRTA |
| DMACDiaMedica Therapeutics Inc. | 7.99 | -1.72% | $430.87M | vs PRTA |
| SPRYARS Pharmaceuticals Inc. | 4.36 | +1.51% | $433.59M | vs PRTA |
| KMDAKamada Ltd. | 7.89 | -2.71% | $455.33M | vs PRTA |
| TTRXTurn Therapeutics Inc. | 12.10 | +3.95% | $367.45M | vs PRTA |
| IRDOpus Genetics Inc. | 4.41 | +0.68% | $366.89M | vs PRTA |
| GALTGalectin Therapeutics Inc. | 3.62 | -3.72% | $365.08M | vs PRTA |